| Literature DB >> 21148719 |
Wan-Lun Hsu1, Kelly J Yu, Yin-Chu Chien, Chun-Ju Chiang, Yu-Juen Cheng, Jen-Yang Chen, Mei-Ying Liu, Sheng-Ping Chou, San-Lin You, Mow-Ming Hsu, Pei-Jen Lou, Cheng-Ping Wang, Ji-Hong Hong, Yi-Shing Leu, Ming-Hsui Tsai, Mao-Chang Su, Sen-Tien Tsai, Wen-Yuan Chao, Luo-Ping Ger, Peir-Rong Chen, Czau-Siung Yang, Allan Hildesheim, Scott R Diehl, Chien-Jen Chen.
Abstract
In the present study, the authors compared the long-term risk of nasopharyngeal carcinoma (NPC) of male participants in an NPC multiplex family cohort with that of controls in a community cohort in Taiwan after adjustment for anti-Epstein-Barr virus (EBV) seromarkers and cigarette smoking. A total of 43 incident NPC cases were identified from the 1,019 males in the NPC multiplex family cohort and the 9,622 males in the community cohort, for a total of 8,061 person-years and 185,587 person-years, respectively. The adjusted hazard ratio was 6.8 (95% confidence interval (CI): 2.3, 20.1) for the multiplex family cohort compared with the community cohort. In the evaluation of anti-EBV viral capsid antigen immunoglobulin A and anti-EBV deoxyribonuclease, the adjusted hazard ratios were 2.8 (95% CI: 1.3, 6.0) and 15.1 (95% CI: 4.2, 54.1) for those positive for 1 EBV seromarker and positive for both seromarkers, respectively, compared with those negative for both EBV seromarkers. The adjusted hazard ratio was 31.0 (95% CI: 9.7, 98.7) for participants who reported a family history of NPC and who were anti-EBV-seropositive compared with individuals without such a history who were anti-EBV-seronegative. The findings suggest that both family history of NPC and anti-EBV seropositivity are important determinants of subsequent NPC risk and that the effect of family history on NPC risk cannot be fully explained by mediation through EBV serologic responses.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21148719 PMCID: PMC3105265 DOI: 10.1093/aje/kwq358
Source DB: PubMed Journal: Am J Epidemiol ISSN: 0002-9262 Impact factor: 4.897